Regeneron Pharmaceuticals Aktie
638,60
EUR
-3,20
EUR
-0,50
%
679,54
USD
+5,88
USD
+0,87
%
Werbung
Regeneron Pharmaceuticals Aktie Analyse
20.10.17 | Regeneron Pharmaceuticals Underweight | Barclays Capital | |
01.08.17 | Regeneron Pharmaceuticals Underperform | Robert W. Baird & Co. Incorporated | |
07.11.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
16.03.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
25.01.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
05.08.15 | Regeneron Pharmaceuticals Sell | UBS AG | |
11.01.05 | Regeneron Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung